229 related articles for article (PubMed ID: 10443606)
1. The effect of prophylactic epsilon-aminocaproic acid on bleeding, transfusions, platelet function, and fibrinolysis during coronary artery bypass grafting.
Troianos CA; Sypula RW; Lucas DM; D'Amico F; Mathie TB; Desai M; Pasqual RT; Pellegrini RV; Newfeld ML
Anesthesiology; 1999 Aug; 91(2):430-5. PubMed ID: 10443606
[TBL] [Abstract][Full Text] [Related]
2. Epsilon-aminocaproic acid in coronary artery bypass graft surgery: preincision or postheparin?
Kluger R; Olive DJ; Stewart AB; Blyth CM
Anesthesiology; 2003 Dec; 99(6):1263-9. PubMed ID: 14639137
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, placebo-controlled trial of epsilon-aminocaproic acid for reducing blood loss in coronary artery bypass grafting surgery.
Kikura M; Levy JH; Tanaka KA; Ramsay JG
J Am Coll Surg; 2006 Feb; 202(2):216-22; quiz A44-5. PubMed ID: 16427545
[TBL] [Abstract][Full Text] [Related]
4. The effects of epsilon-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery.
Slaughter TF; Faghih F; Greenberg CS; Leslie JB; Sladen RN
Anesth Analg; 1997 Dec; 85(6):1221-6. PubMed ID: 9390584
[TBL] [Abstract][Full Text] [Related]
5. Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass grafting. A randomized, prospective, double-blind study.
Daily PO; Lamphere JA; Dembitsky WP; Adamson RM; Dans NF
J Thorac Cardiovasc Surg; 1994 Jul; 108(1):99-106; discussion 106-8. PubMed ID: 8028387
[TBL] [Abstract][Full Text] [Related]
6. Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: Comparison between on-pump and off-pump techniques.
Casati V; Della Valle P; Benussi S; Franco A; Gerli C; Baili P; Alfieri O; D'Angelo A
J Thorac Cardiovasc Surg; 2004 Jul; 128(1):83-91. PubMed ID: 15224025
[TBL] [Abstract][Full Text] [Related]
7. Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery. Prospective trial of 3 antifibrinolytic drugs.
Penta de Peppo A; Pierri MD; Scafuri A; De Paulis R; Colantuono G; Caprara E; Tomai F; Chiariello L
Tex Heart Inst J; 1995; 22(3):231-6. PubMed ID: 7580360
[TBL] [Abstract][Full Text] [Related]
8. High-dose epsilon-aminocaproic acid versus aprotinin: antifibrinolytic efficacy in first-time coronary operations.
Eberle B; Mayer E; Hafner G; Heinermann J; Dahm M; Prellwitz W; Dick W; Oelert H
Ann Thorac Surg; 1998 Mar; 65(3):667-73. PubMed ID: 9527193
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, and placebo-controlled study with tranexamic acid of bleeding and fibrinolytic activity after primary coronary artery bypass grafting.
Santos AT; Kalil RA; Bauemann C; Pereira JB; Nesralla IA
Braz J Med Biol Res; 2006 Jan; 39(1):63-9. PubMed ID: 16400465
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass.
Andreasen JJ; Nielsen C
Eur J Cardiothorac Surg; 2004 Aug; 26(2):311-7. PubMed ID: 15296889
[TBL] [Abstract][Full Text] [Related]
11. Antifibrinolytic therapy during cardiopulmonary bypass reduces proinflammatory cytokine levels: a randomized, double-blind, placebo-controlled study of epsilon-aminocaproic acid and aprotinin.
Greilich PE; Brouse CF; Whitten CW; Chi L; Dimaio JM; Jessen ME
J Thorac Cardiovasc Surg; 2003 Nov; 126(5):1498-503. PubMed ID: 14666025
[TBL] [Abstract][Full Text] [Related]
12. Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials.
Lu J; Meng H; Meng Z; Sun Y; Pribis JP; Zhu C; Li Q
Int J Clin Exp Pathol; 2015; 8(7):7978-87. PubMed ID: 26339364
[TBL] [Abstract][Full Text] [Related]
13. Reduction of bleeding after heart operations through the prophylactic use of epsilon-aminocaproic acid.
Vander Salm TJ; Kaur S; Lancey RA; Okike ON; Pezzella AT; Stahl RF; Leone L; Li JM; Valeri CR; Michelson AD
J Thorac Cardiovasc Surg; 1996 Oct; 112(4):1098-107. PubMed ID: 8873738
[TBL] [Abstract][Full Text] [Related]
14. Aprotinin but not epsilon-aminocaproic acid decreases interleukin-10 after cardiac surgery with extracorporeal circulation: randomized, double-blind, placebo-controlled study in patients receiving aprotinin and epsilon-aminocaproic acid.
Greilich PE; Okada K; Latham P; Kumar RR; Jessen ME
Circulation; 2001 Sep; 104(12 Suppl 1):I265-9. PubMed ID: 11568067
[TBL] [Abstract][Full Text] [Related]
15. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
[TBL] [Abstract][Full Text] [Related]
16. Topical use of antifibrinolytic agent to reduce postoperative bleeding after coronary artery bypass surgery.
Breda JR; Gurian DB; Breda AS; Meneghine A; Freitas AC; Matos LL; Abreu LC; Pires AC
Rev Bras Cir Cardiovasc; 2009; 24(3):341-5. PubMed ID: 20011881
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic tranexamic acid and epsilon-aminocaproic acid for primary myocardial revascularization.
Hardy JF; Bélisle S; Dupont C; Harel F; Robitaille D; Roy M; Gagnon L
Ann Thorac Surg; 1998 Feb; 65(2):371-6. PubMed ID: 9485231
[TBL] [Abstract][Full Text] [Related]
18. The effect of epsilon-aminocaproic acid and aprotinin on fibrinolysis and blood loss in patients undergoing primary, isolated coronary artery bypass surgery: a randomized, double-blind, placebo-controlled, noninferiority trial.
Greilich PE; Jessen ME; Satyanarayana N; Whitten CW; Nuttall GA; Beckham JM; Wall MH; Butterworth JF
Anesth Analg; 2009 Jul; 109(1):15-24. PubMed ID: 19535691
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of the topical effect of antifibrinolytic epsilon aminocaproic Acid on coronary artery bypass surgery without cardiopulmonary bypass.
Gurian DB; Meneghini A; Abreu LC; Murad N; Matos LL; Pires AC; Valenti VE; Breda JR
Clin Appl Thromb Hemost; 2014 Sep; 20(6):615-20. PubMed ID: 23434921
[TBL] [Abstract][Full Text] [Related]
20. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
